Personalis, Inc. (PSNL)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$17.20+2.20%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · PSNL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 69.7 | 69.6 | 84.6 | 73.5 | 65.0 | 85.5 | 78.6 | 65.2 |
| Cost of Revenues | 60.8 | 53.9 | 57.8 | 55.3 | 51.7 | 53.8 | 58.5 | 43.1 |
| Operating Expenses & Income | ||||||||
| Selling, General & Admin | 67.0 | 53.6 | 46.2 | 49.7 | 64.0 | 47.7 | 33.7 | 22.1 |
| R&D Expenses | 56.1 | 50.3 | 48.9 | 64.8 | 64.9 | 49.3 | 28.6 | 22.4 |
| Operating Income | (114.3) | (88.1) | (68.3) | (109.9) | (115.5) | (65.4) | (42.1) | (22.4) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | 0.2 | 0.2 | 0.0 | 0.1 | 0.2 | 0.2 | 0.0 | 1.1 |
| Interest & Investment Income | 7.4 | 7.2 | 5.5 | 5.9 | 2.4 | 0.4 | 0.9 | 1.6 |
| Net Interest Expenses | — | — | — | (5.8) | (2.2) | (0.2) | (0.9) | (0.5) |
| EBT, Incl. Unusual Items | (107.1) | (81.2) | (81.3) | (108.2) | (113.3) | (65.2) | (41.2) | (25.1) |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
| Net Income | ||||||||
| Net Income | (107.2) | (81.3) | (81.3) | (108.3) | (113.3) | (65.2) | (41.3) | (25.1) |
| Per Share | ||||||||
| Basic EPS | (1.02) | (0.91) | (1.37) | (2.25) | (2.48) | (1.49) | (1.20) | — |
| Diluted EPS | (1.02) | (0.91) | (1.37) | (2.25) | (2.48) | (1.49) | (1.20) | — |
| Revenue per Share | 0.66 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 105.4 | 89.2 | 59.3 | 48.2 | 45.7 | 43.9 | 34.4 | 18.0 |
| Diluted Weighted Avg Shares | 105.4 | 89.2 | 59.3 | 48.2 | 45.7 | 43.9 | 34.4 | — |
| Supplemental | ||||||||
| EBITDA | — | (78.3) | (57.3) | (98.2) | (107.1) | (59.3) | (36.4) | (17.7) |
| EBIT | (114.3) | (88.1) | (68.3) | (109.9) | (115.5) | (65.4) | (42.1) | (22.4) |
| Effective Tax Rate | -0.0% | — | — | -0.1% | -0.0% | -0.0% | -0.1% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.